434 related articles for article (PubMed ID: 19124382)
21. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
22. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
23. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
Rahman I
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
Wang XL; Li T; Li JH; Miao SY; Xiao XZ
Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells.
Lakshmi SP; Reddy AT; Kodidhela LD; Varadacharyulu NC
Life Sci; 2020 Oct; 259():118260. PubMed ID: 32795541
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
28. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
Rahman I
Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress in patients with COPD.
Loukides S; Bakakos P; Kostikas K
Curr Drug Targets; 2011 Apr; 12(4):469-77. PubMed ID: 21194408
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress in COPD.
Kirkham PA; Barnes PJ
Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
[TBL] [Abstract][Full Text] [Related]
31. Oxidants and COPD.
MacNee W
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
[TBL] [Abstract][Full Text] [Related]
32. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
33. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
[TBL] [Abstract][Full Text] [Related]
34. The pharmokinetic limitations of antioxidant treatment for COPD.
Foronjy R; Wallace A; D'Armiento J
Pulm Pharmacol Ther; 2008; 21(2):370-9. PubMed ID: 18054260
[TBL] [Abstract][Full Text] [Related]
35. Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice.
Ng DS; Liao W; Tan WS; Chan TK; Loh XY; Wong WS
Phytomedicine; 2014 Oct; 21(12):1638-44. PubMed ID: 25442271
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
38. Role of oxidative stress in the pathogenesis of COPD.
Nucera F; Mumby S; Paudel KR; Dharwal V; DI Stefano A; Casolaro V; Hansbro PM; Adcock IM; Caramori G
Minerva Med; 2022 Jun; 113(3):370-404. PubMed ID: 35142479
[TBL] [Abstract][Full Text] [Related]
39. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
Lin JL; Thomas PS
COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
[TBL] [Abstract][Full Text] [Related]
40. Oxidants/antioxidants and COPD.
MacNee W
Chest; 2000 May; 117(5 Suppl 1):303S-17S. PubMed ID: 10843965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]